Global point of care testing market is expected develop at a CAGR of over 7.4% throughout the forthcoming years and industry is worth at over USD 21.7 billion in 2018 and is likely to rise up to USD 38.40 billion by 2026.
Increment in number of individuals experiencing infectious sicknesses and chronic conditions in developing countries, for example, China and India will support the demand and adoption rate of point of care testing molecular diagnostic services. As per the statistics published by a UK-based association, Avert, there were around 88,000 new incidence and almost 69,000 deaths because of HIV disease in India in the year 2017. Subsequently, developing commonness and consciousness of infectious illnesses will animate the development of point of care testing devices market later on.
Recent technological advancements in point of care testing devices will increase the business development in the forthcoming years. Utilization of a few unique combinations, for example, bio-sensing stages with cell phone coordinated electronic readers will give exact nearby and on-time diagnostics. With healthcare frameworks concentrating more on populace health, accuracy medication and the executives of perpetual ailment, effect of point of care testing keeps on developing, and a few noticeable point of care testing demonstrative patterns have risen in the most recent decade, increasing the market development.
Molecular diagnostics holds noteworthy job in the field of microbiology. Traditional culture technique isn't useful in acquiring auspicious outcomes. Molecular testing technology permits nucleic acid detection straightforwardly through intensification and screening of test. Ongoing PCR is utilized for this reason. Industry players have been concentrating their endeavours on growing new point of care testingatomic demonstrative advances to convey quicker outcomes with high exactness and explicitness. Henceforth, increment in innovative work will increase the market development in the anticipated years.
High expense of the point of care testing devices will be one of the main considerations in charge of obstructing market development in the forthcoming years. The expense of individual point of care testing tests are generally higher than the tests performed on large platforms. Henceforth, surprising expense of the testing devices will result in decline in device adoption, in this way controlling the market development.
Germany overwhelmed the Europe POC testing market and was esteemed around USD 1,718.4 million in the year 2018. In the Federal Republic of Germany, purpose of-care frameworks are progressively utilized inside hospitals and medical practices. Other therapeutic offices where point of care testing is generally utilized incorporates outpatient nursing care, drug stores and home visits. Along these lines, developing reception of point of care testing the country over will drive the provincial market development.
Japan POC testing market is anticipated to develop at a CAGR of 8.7% over the projection time frame. According to the measurements distributed by the World Health Organization (WHO), in excess of 20,000 individuals were experiencing HIV and tuberculosis in Japan in the year 2016. This rising rate animates the demand for point of care testingdiagnostics tests bringing about developing demand and selection rate of point of care testing gadgets in the nation.
Few of the significant contributor in the global point of care industry are Abaxis, Abbott, Siemens AG, F. Hoffmann-La Roche Ltd., and Johnson and Johnson.
Market By Product
Cardiometabolic testing products
Infectious disease testing products
Coagulation testing products
Pregnancy and fertility testing products
Tumor/Cancer marker testing products
Urinalysis testing products
Cholesterol testing products
Hematology testing products
Drug-of-Abuse (DoA) testing products
Fecal occult testing products
Market By Technology
Lateral flow assays
Market By Prescription
Market By Application
Cardio metabolic testing
Infectious disease testing
Drug-of-Abuse (DoA) testing
Blood glucose testing
Cancer biomarker testing
Market By End-user
Market By Region
Middle East & Africa